Stifel Maintains Buy on Inspire Medical Systems, Lowers Price Target to $250
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Jonathan Block has maintained a 'Buy' rating on Inspire Medical Systems (NYSE:INSP) but lowered the price target from $350 to $250.
November 07, 2023 | 3:03 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Inspire Medical Systems' price target has been lowered from $350 to $250 by Stifel, though the 'Buy' rating is maintained.
The news is directly about Inspire Medical Systems. The lowering of the price target might indicate a potential downside, but the maintained 'Buy' rating suggests that the analyst still sees value in the stock. This could lead to mixed reactions in the market, hence the neutral score.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100